Stuart J Schnitt Selected Research

Breast Diseases (Breast Disease)

1/2017	EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
1/2015	Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease.
7/2012	Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease.
5/2012	Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease.
1/2010	Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
10/2009	Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue.
7/2004	A prospective study of diet and benign breast disease.
6/2003	Benign breast disease and breast cancer risk: morphology and beyond.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart J Schnitt Research Topics

Disease

70	Breast Neoplasms (Breast Cancer) 11/2022 - 09/2002
57	Neoplasms (Cancer) 11/2022 - 01/2002
29	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2022 - 09/2002
10	Triple Negative Breast Neoplasms 01/2022 - 07/2009
8	Breast Diseases (Breast Disease) 01/2017 - 06/2003
6	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
5	Pathologic Complete Response 11/2022 - 02/2007
4	Breast Carcinoma In Situ 10/2022 - 10/2013
4	Lobular Carcinoma 10/2022 - 07/2013
4	Carcinogenesis 01/2017 - 01/2010
2	Residual Neoplasm 11/2022 - 11/2022
2	Hyperplasia 03/2022 - 03/2021
2	Intraductal Papilloma 01/2020 - 08/2006
2	Papillary Carcinoma 01/2020 - 08/2006
2	Necrosis 01/2018 - 12/2009
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Ductal Carcinoma 01/2016 - 05/2004
2	Margins of Excision 07/2012 - 01/2010
1	Mucocele 01/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2020
1	Acinar Cell Carcinoma 01/2017
1	Confusion (Bewilderment) 07/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Weight Gain 01/2012

Drug/Important Bio-Agent (IBA)

28	Estrogen ReceptorsIBA 01/2022 - 10/2004
18	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2006
16	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 10/2004
10	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2008
9	Hormones (Hormone)IBA 11/2022 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
6	Biological ProductsIBA 11/2022 - 06/2003
6	human ERBB2 proteinIBA 10/2020 - 02/2007
6	Tamoxifen FDA LinkGeneric 01/2019 - 05/2005
6	ParaffinIBA 01/2018 - 01/2005
5	Cadherins (E-Cadherin)IBA 10/2022 - 07/2013
5	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 04/2011
4	ORALIT (ORS)IBA 03/2021 - 04/2009
4	AntibodiesIBA 01/2020 - 05/2006
4	ErbB Receptors (EGF Receptor)IBA 10/2012 - 07/2009
4	Keratins (Keratin)IBA 02/2011 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2010
2	MucinsIBA 10/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2016
2	Monoclonal AntibodiesIBA 01/2020 - 12/2019
2	AndrogensIBA 01/2019 - 02/2014
2	Formaldehyde (Formol)FDA Link 01/2018 - 01/2015
2	Vitamin D FDA LinkGeneric 02/2014 - 07/2012
2	Estrogens (Estrogen)FDA Link 02/2014 - 10/2004
2	Messenger RNA (mRNA)IBA 11/2011 - 01/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 01/2002
2	CalponinsIBA 02/2009 - 08/2006
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2009 - 08/2006
2	Trastuzumab (Herceptin)FDA Link 02/2007 - 03/2004
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	cabozantinibIBA 08/2021
1	NivolumabIBA 08/2021
1	Platinum Compounds (Compounds, Platinum)IBA 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	atezolizumabIBA 01/2020
1	Retinoblastoma ProteinIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Aromatase InhibitorsIBA 01/2019
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2017
1	Polycomb-Group ProteinsIBA 01/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	B7-H1 AntigenIBA 01/2016
1	MicronutrientsIBA 01/2015
1	N 30IBA 01/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Lysine (L-Lysine)FDA Link 10/2014
1	Histones (Histone)IBA 10/2014
1	CateninsIBA 07/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2012
1	CalciumIBA 07/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2012
1	Indicators and Reagents (Reagents)IBA 11/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2011

Therapy/Procedure

30	Therapeutics 11/2022 - 03/2004
19	Segmental Mastectomy (Lumpectomy) 10/2020 - 09/2002
7	Radiotherapy 01/2020 - 05/2005
6	Neoadjuvant Therapy 11/2022 - 07/2019
3	Drug Therapy (Chemotherapy) 11/2022 - 07/2011
3	Aftercare (After-Treatment) 07/2009 - 09/2002
1	Contraindications 11/2022
1	Conservative Treatment 03/2022
1	Lymph Node Excision (Lymph Node Dissection) 11/2019
1	Precision Medicine 10/2017
1	Punctures 01/2015
1	Ovariectomy (Oophorectomy) 07/2014